GSK3B and columnar cell hyperplasia of the breast: In addition to cholinergic abnormalities, CCH treatment induced learning/memory alterations, increased microtubule-associated protein tau hyperphosphorylation, and caused imbalances in the phosphorylation system by activating glycogen synthase kinase 3β (GSK-3β) and Akt10.